The core acceptance indicators for tea tree oil are measured Terpinen-4-ol ≥40% under ISO 4730:2017, 1,8-Cineole ≤15%, p-Cymene ≤2%, batch variation below ±2% (SD ≤±1.5%), with OOS investigation on any out-of-spec value and chiral R/S analysis required to prove natural origin.
The core acceptance indicators for tea tree oil are measured Terpinen-4-ol ≥40% under ISO 4730:2017, 1,8-Cineole ≤15%, p-Cymene ≤2%, batch variation below ±2% (SD ≤±1.5%), with OOS investigation on any out-of-spec value and chiral R/S analysis required to prove natural origin.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
The key ingredient specifications for importing neroli oil into the US are Linalool 39–53% (minimum ≥39%), Linalyl acetate 9–20% (minimum ≥9%), density 0.8630–0.8760, with batch-to-batch GC-MS variation ≤3% (>5% direct reject) and FDA/MoCRA, IFRA and Lacey Act compliance documents.
